Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002512823 | SCV003441505 | uncertain significance | not provided | 2024-12-03 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 13 of the ADAMTS13 gene. It does not directly change the encoded amino acid sequence of the ADAMTS13 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs782235228, gnomAD 0.003%). This variant has been observed in individual(s) with thrombotic thrombocytopenic purpura (PMID: 11586351). ClinVar contains an entry for this variant (Variation ID: 5810). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000006166 | SCV005677979 | likely pathogenic | Upshaw-Schulman syndrome | 2024-05-03 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000006166 | SCV000026348 | pathogenic | Upshaw-Schulman syndrome | 2001-10-04 | no assertion criteria provided | literature only |